Neurocrine Biosciences (NASDAQ:NBIX) reported its Q4 earnings results on Friday, February 11, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Neurocrine Biosciences reported an EPS of $0.04.
Revenue was up $64.10 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04, which was followed by a 10.02% drop in the share price the next day.
Here's a look at Neurocrine Biosciences's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.60 | 0.49 | 0.51 | 0.54 |
| EPS Actual | 0.64 | 0.63 | 0.49 | 0.91 |
| Revenue Estimate | 297.65M | 274.38M | 250.63M | 262.40M |
| Revenue Actual | 296.00M | 288.90M | 236.60M | 247.90M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
